[go: up one dir, main page]

AU2016100865A4 - Multi-strain probiotic composition - Google Patents

Multi-strain probiotic composition

Info

Publication number
AU2016100865A4
AU2016100865A4 AU2016100865A AU2016100865A AU2016100865A4 AU 2016100865 A4 AU2016100865 A4 AU 2016100865A4 AU 2016100865 A AU2016100865 A AU 2016100865A AU 2016100865 A AU2016100865 A AU 2016100865A AU 2016100865 A4 AU2016100865 A4 AU 2016100865A4
Authority
AU
Australia
Prior art keywords
probiotic composition
cfu
billion
strain probiotic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2016100865A
Inventor
Neal Mercado
Jodi Van Dyk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FIT-BIOCEUTICALS Pty Ltd
Original Assignee
Fit Bioceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fit Bioceuticals Ltd filed Critical Fit Bioceuticals Ltd
Priority to AU2016100865A priority Critical patent/AU2016100865A4/en
Application granted granted Critical
Publication of AU2016100865A4 publication Critical patent/AU2016100865A4/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention provides a probiotic composition for re-colonizing a microbiota and/or for treating or preventing dysbiosis in a subject, wherein the composition comprises at least 8 probiotic bacterial strains in a total amount of greater than 100 billion colony forming units (CFU), preferably greater than 450 billion CFU, more preferably in an amount of about 500 billion CFU.
AU2016100865A 2016-06-14 2016-06-14 Multi-strain probiotic composition Expired AU2016100865A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2016100865A AU2016100865A4 (en) 2016-06-14 2016-06-14 Multi-strain probiotic composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2016100865A AU2016100865A4 (en) 2016-06-14 2016-06-14 Multi-strain probiotic composition

Publications (1)

Publication Number Publication Date
AU2016100865A4 true AU2016100865A4 (en) 2016-07-14

Family

ID=56409387

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016100865A Expired AU2016100865A4 (en) 2016-06-14 2016-06-14 Multi-strain probiotic composition

Country Status (1)

Country Link
AU (1) AU2016100865A4 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019084617A1 (en) * 2017-11-01 2019-05-09 Medlab Ip Pty Ltd Modulation of intestinal microbiota in pre-diabetes and type 2 diabetes
WO2020229924A1 (en) * 2019-05-14 2020-11-19 Ormendes Sa Use of bacillus amyloliquefaciens and/or bacillus subtilis for the enhancement of active probiotic compositions or for the activation of inactive probiotic compositions, compositions thus obtained, and related method
WO2021127164A1 (en) * 2019-12-17 2021-06-24 Metagenics, Inc. Multi-strain probiotic composition and its use
WO2021214139A1 (en) * 2020-04-21 2021-10-28 Giellepi S.P.A. Composition for use in the treatment of group-b streptococcus (gbs) infections
CN113969250A (en) * 2021-11-22 2022-01-25 山东渤海实业集团有限公司 Lactobacillus casei DY13 and product and application thereof
IT202100007682A1 (en) * 2021-03-29 2022-09-29 Synbalance Srl PROBIOTIC COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF GASTROINTESTINAL DISORDERS
WO2023001939A1 (en) * 2021-07-20 2023-01-26 Eth Zurich Treatment and/or prevention of digestive disorder by a bacterial composition of propionibacterium freudenreichii and bifidobacterium longum
EP4178597A4 (en) * 2020-07-09 2024-07-17 International N&H Denmark ApS PROBIOTICS FOR USE IN THE PREVENTION OR TREATMENT OF DISEASES AND/OR SYMPTOMS ASSOCIATED WITH CORONAVIRUS
RU2848673C1 (en) * 2025-06-11 2025-10-21 Общество с ограниченной ответственностью "БИННОФАРМ ГРУПП" Probiotic composition for normalising microflora of gastrointestinal tract

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019084617A1 (en) * 2017-11-01 2019-05-09 Medlab Ip Pty Ltd Modulation of intestinal microbiota in pre-diabetes and type 2 diabetes
WO2020229924A1 (en) * 2019-05-14 2020-11-19 Ormendes Sa Use of bacillus amyloliquefaciens and/or bacillus subtilis for the enhancement of active probiotic compositions or for the activation of inactive probiotic compositions, compositions thus obtained, and related method
CN113825519A (en) * 2019-05-14 2021-12-21 奥尔门德斯公司 Use of bacillus amyloliquefaciens and/or bacillus subtilis for enhancing active probiotic compositions or for activating inactive probiotic compositions, compositions obtained thereby and related methods
US20220160794A1 (en) * 2019-05-14 2022-05-26 Ormendes Sa Use of bacillus amyloliquefaciens and/or bacillus subtilis for the enhancement of active probiotic compositions or for the activation of inactive probiotic compositions, compositions thus obtained, and related method
JP2023507383A (en) * 2019-12-17 2023-02-22 メタジェニックス，インコーポレイティド Multi-strain probiotic compositions and uses thereof
WO2021127164A1 (en) * 2019-12-17 2021-06-24 Metagenics, Inc. Multi-strain probiotic composition and its use
AU2020405028B2 (en) * 2019-12-17 2023-11-09 Metagenics LLC Multi-strain probiotic composition and its use
CN115066187A (en) * 2019-12-17 2022-09-16 麦特珍尼斯公司 Multi-strain probiotic composition and application thereof
WO2021214139A1 (en) * 2020-04-21 2021-10-28 Giellepi S.P.A. Composition for use in the treatment of group-b streptococcus (gbs) infections
EP4178597A4 (en) * 2020-07-09 2024-07-17 International N&H Denmark ApS PROBIOTICS FOR USE IN THE PREVENTION OR TREATMENT OF DISEASES AND/OR SYMPTOMS ASSOCIATED WITH CORONAVIRUS
IT202100007682A1 (en) * 2021-03-29 2022-09-29 Synbalance Srl PROBIOTIC COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF GASTROINTESTINAL DISORDERS
WO2023001939A1 (en) * 2021-07-20 2023-01-26 Eth Zurich Treatment and/or prevention of digestive disorder by a bacterial composition of propionibacterium freudenreichii and bifidobacterium longum
CN113969250B (en) * 2021-11-22 2023-03-03 山东渤海实业集团有限公司 Lactobacillus casei DY13 and its products and applications
CN113969250A (en) * 2021-11-22 2022-01-25 山东渤海实业集团有限公司 Lactobacillus casei DY13 and product and application thereof
RU2848673C1 (en) * 2025-06-11 2025-10-21 Общество с ограниченной ответственностью "БИННОФАРМ ГРУПП" Probiotic composition for normalising microflora of gastrointestinal tract

Similar Documents

Publication Publication Date Title
AU2016100865A4 (en) Multi-strain probiotic composition
WO2016086210A8 (en) Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease
NZ777234A (en) Compositions comprising bacterial strains
MX2017011669A (en) Compositions that metabolize or sequester free sugar monomers and uses thereof.
WO2020074547A8 (en) Lactobacillus crispatus probiotic strains suitable for treating urogenital yeast and bacterial infections
AU2018263868A1 (en) Formulations of anti-LAG3 antibodies and co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies
BR112018075833A2 (en) compositions comprising bacterial strains
SG10201910740UA (en) Lactobacillus fermentum gkf3, composition comprising the strain and method for improving psychataxia using the same
HK1254843A1 (en) Compositions comprising bacterial strains
WO2020120714A8 (en) Compositions comprising bacterial strains
EP4293033A3 (en) Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides
EP4086335A4 (en) Lactobacillus fermentum strain, and composition for preventing or treating metabolic diseases, comprising same
PH12017502042A1 (en) Dietary supplement
PL3412766T3 (en) Lactobacillus salivarius strain, composition comprising the same, and uses thereof
PH12019502341A1 (en) Compositions and methods involving probiotic molecules
WO2020091180A3 (en) Composition for preventing or treating secondary osteoporosis comprising probiotics as active ingredient
PH12018550110B1 (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
PH12015500091B1 (en) Non-pathogenic f18 e.coli strain and use thereof
MX2020001632A (en) Compositions comprising bacterial strains.
WO2020091179A3 (en) Composition for preventing or treating secondary osteoporosis comprising probiotics as active ingredient
MY202532A (en) Therapeutic uses of lactobacillus plantarum
WO2017123610A3 (en) Bacteria engineered to detoxify deleterious molecules
EP4134090A4 (en) Probiotic composition for treating rapid eye movement sleep behavior disorder, formulation and use
MX2021004150A (en) Compositions comprising bacterial strains.
MX2017007969A (en) Lactic acid bacteria and their use for the treatment of mastitis.

Legal Events

Date Code Title Description
FGI Letters patent sealed or granted (innovation patent)